Pfizer Q4 Results
- BSE: 500680
- NSE: PFIZER
- ISIN: INE182A01018
- Sector: Major Drugs
BSE
4,870
-114.50 (-2.30%)
-114.50 (-2.30%)Volume812.00
Updated: Fri 14 Aug, 2026 | 15:28:39
NSE
4,864-126.40 (-2.53%)
-126.40 (-2.53%)Volume11.70 K
Updated: Fri 14 Aug, 2026 | 15:29:49
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Pfizer Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 399.02 | 489.30 | -18.45% | 370.95 | 4.78% |
| Depreciation/ Amortization | 14.78 | 14.26 | 3.65% | 13.75 | -9.88% |
| Operating Income | 230.21 | 155.73 | 47.83% | 175.68 | 9.05% |
| Net Income | 199.82 | 141.84 | 40.88% | 178.86 | -39.62% |
| Other Operating Expenses Total | 95.74 | 91.77 | 4.33% | 92.75 | 21.16% |
| Net Income Before Taxes | 268.82 | 191.95 | 40.05% | 243.86 | -36.87% |
| Total Revenue | 629.23 | 645.03 | -2.45% | 546.63 | 6.31% |
| Selling/ General/ Admin Expenses Total | 77.18 | 100.30 | -23.05% | 75.11 | -6.91% |
| Diluted Normalized EPS | 42.21 | 40.41 | 4.44% | 39.09 | -1.83% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.